Fmoc-Val-Cit-PAB-Duocarmycin TM

Fmoc-Val-Cit-PAB-Duocarmycin TM Catalog number: BADC-00871

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Fmoc-Val-Cit-PAB-Duocarmycin TM is a drug-linker conjugate for ADC by using the antitumor antibiotic, Duocarmycin TM, linked via Fmoc-Val-Cit-PAB.

Category
ADCs Cytotoxin
Product Name
Fmoc-Val-Cit-PAB-Duocarmycin TM
Catalog Number
BADC-00871
Molecular Formula
C58H60ClN7O10
Molecular Weight
1050.59
Purity
>98.0%

Ordering Information

Catalog Number Size Price Quantity
BADC-00871 -- $-- Inquiry
Description
Fmoc-Val-Cit-PAB-Duocarmycin TM is a drug-linker conjugate for ADC by using the antitumor antibiotic, Duocarmycin TM, linked via Fmoc-Val-Cit-PAB.
Solubility
10 mm in DMSO
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
Room temperature
Storage
Store at -5°C,keep in dry and avoid sunlight.

Fmoc-Val-Cit-PAB-Duocarmycin TM is a specialized chemical linker used in the development of targeted cancer therapies. Here are some key applications of Fmoc-Val-Cit-PAB-Duocarmycin TM:

Antibody-Drug Conjugates (ADCs): Fmoc-Val-Cit-PAB-Duocarmycin TM is used as a linker in ADCs, which are designed to deliver cytotoxic drugs specifically to cancer cells. The linker ensures that the drug remains inactive until it reaches the target cells, minimizing damage to normal tissues. This enhances the efficacy of cancer treatments while reducing systemic toxicity.

Targeted Drug Delivery: The Fmoc-Val-Cit-PAB-Duocarmycin TM linker is employed in the precise delivery of chemotherapeutic agents to tumors. By attaching cytotoxic drugs to targeting moieties, like antibodies or peptides, the linker facilitates selective drug release within the cancerous microenvironment. This targeted approach aims to maximize drug concentration at the tumor site, improving therapeutic outcomes.

Protease-Sensitive Linkers: Fmoc-Val-Cit-PAB-Duocarmycin TM utilizes a valine-citrulline dipeptide sequence that is sensitive to enzymatic cleavage by specific proteases present in the tumor microenvironment. Upon cleavage, the drug is activated and exerts its cytotoxic effects on the tumor cells. This protease-sensitive mechanism ensures that the drug is released specifically at the cancer site, minimizing off-target effects.

Drug Design and Development: Researchers use Fmoc-Val-Cit-PAB-Duocarmycin TM to study and optimize the design of new drug-linker combinations for improved cancer therapies. By investigating the stability, cleavage efficiency, and release profiles of various linker-drug constructs, scientists can develop more effective and safer ADCs. This research supports the innovation of next-generation targeted cancer treatments.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Questions & Comments
Verification code
Send Inquiry
Verification code
Resources & Supports
Inquiry Basket